Aspen Pharmacare Holdings Ltd (JSE:APN) — Stock Price

ZAC15221.00 ZAC
▼ -0.09% today

Aspen Pharmacare Holdings Ltd (JSE:APN) is currently trading at ZAC15221.00 ZAC, down 0.09% today. Over the past 52 weeks, shares have ranged between ZAC9100.00 and ZAC15855.00. This page tracks Aspen Pharmacare Holdings Ltd's live share price on the JSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see APN company net worth.

Aspen Pharmacare Holdings Ltd (APN) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Aspen Pharmacare Holdings Ltd's daily closing share price and trading volume on the JSE exchange over the past year, giving a clear view of recent price momentum and liquidity.

Aspen Pharmacare Holdings Ltd Income Statement — Revenue, Profit & Earnings by Year

Aspen Pharmacare Holdings Ltd's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue ZAC43.36 Billion ZAC44.71 Billion ZAC40.71 Billion ZAC38.61 Billion ZAC37.77 Billion
Cost of Revenue ZAC24.23 Billion ZAC25.29 Billion ZAC22.30 Billion ZAC20.30 Billion ZAC19.98 Billion
Gross Profit ZAC19.13 Billion ZAC19.42 Billion ZAC18.41 Billion ZAC18.31 Billion ZAC17.79 Billion
Research & Development — ZAC162.00 Million ZAC214.00 Million ZAC433.00 Million ZAC260.00 Million
SG&A ZAC3.95 Billion ZAC3.63 Billion ZAC1.68 Billion ZAC1.48 Billion ZAC1.84 Billion
Total Operating Expenses ZAC17.69 Billion ZAC12.42 Billion ZAC9.46 Billion ZAC9.47 Billion ZAC8.60 Billion
Operating Income ZAC1.44 Billion ZAC7.00 Billion ZAC7.82 Billion ZAC8.67 Billion ZAC7.07 Billion
EBITDA ZAC2.16 Billion ZAC9.90 Billion ZAC9.67 Billion ZAC10.61 Billion ZAC8.67 Billion
EBIT ZAC1.53 Billion ZAC7.93 Billion ZAC7.88 Billion ZAC8.90 Billion ZAC7.03 Billion
Interest Expense ZAC1.71 Billion ZAC2.23 Billion ZAC1.32 Billion ZAC765.00 Million ZAC1.21 Billion
Income Before Tax ZAC-123.00 Million ZAC5.71 Billion ZAC6.55 Billion ZAC8.13 Billion ZAC5.99 Billion
Income Tax Expense ZAC960.00 Million ZAC1.31 Billion ZAC1.33 Billion ZAC1.65 Billion ZAC1.19 Billion
Net Income ZAC-1.08 Billion ZAC4.40 Billion ZAC5.23 Billion ZAC6.49 Billion ZAC4.81 Billion

Aspen Pharmacare Holdings Ltd Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Aspen Pharmacare Holdings Ltd's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets ZAC135.89 Billion ZAC139.16 Billion ZAC134.28 Billion ZAC111.38 Billion ZAC109.68 Billion
Total Current Assets ZAC38.70 Billion ZAC44.09 Billion ZAC44.50 Billion ZAC34.56 Billion ZAC32.70 Billion
Cash & Equivalents — — — — —
Short-term Investments — — — ZAC318.00 Million ZAC9.00 Million
Net Receivables ZAC13.34 Billion ZAC11.46 Billion ZAC11.44 Billion ZAC9.61 Billion ZAC10.44 Billion
Inventory ZAC18.01 Billion ZAC18.00 Billion ZAC19.61 Billion ZAC15.76 Billion ZAC13.41 Billion
Property, Plant & Equipment — — ZAC18.90 Billion ZAC16.22 Billion ZAC15.23 Billion
Goodwill ZAC5.20 Billion ZAC5.46 Billion ZAC5.60 Billion ZAC5.01 Billion ZAC4.62 Billion
Total Liabilities ZAC51.00 Billion ZAC54.29 Billion ZAC48.05 Billion ZAC40.43 Billion ZAC44.06 Billion
Total Current Liabilities ZAC17.50 Billion ZAC24.38 Billion ZAC23.15 Billion ZAC23.39 Billion ZAC36.75 Billion
Long-term Debt ZAC31.51 Billion ZAC24.82 Billion ZAC21.38 Billion ZAC105.00 Million ZAC0.00
Net Debt ZAC29.71 Billion ZAC24.12 Billion ZAC18.37 Billion ZAC16.06 Billion ZAC16.33 Billion
Total Stockholder Equity ZAC84.89 Billion ZAC84.86 Billion ZAC86.24 Billion ZAC70.94 Billion ZAC65.63 Billion
Retained Earnings ZAC58.09 Billion ZAC60.76 Billion ZAC58.13 Billion ZAC54.34 Billion ZAC50.76 Billion

Aspen Pharmacare Holdings Ltd Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Aspen Pharmacare Holdings Ltd generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow ZAC5.16 Billion ZAC6.22 Billion ZAC5.52 Billion ZAC5.37 Billion ZAC6.83 Billion
Capital Expenditures ZAC5.05 Billion ZAC5.54 Billion ZAC3.18 Billion ZAC2.70 Billion ZAC3.43 Billion
Free Cash Flow ZAC104.00 Million ZAC690.00 Million ZAC2.34 Billion ZAC2.68 Billion ZAC3.39 Billion
Investing Cash Flow ZAC-5.22 Billion ZAC-9.47 Billion ZAC-3.42 Billion ZAC-2.16 Billion ZAC9.76 Billion
Financing Cash Flow ZAC-162.00 Million ZAC3.62 Billion ZAC-420.00 Million ZAC-4.68 Billion ZAC-15.65 Billion
Dividends Paid ZAC-1.60 Billion ZAC-1.52 Billion ZAC-1.46 Billion ZAC-1.20 Billion ZAC1.20 Billion
Stock-Based Compensation ZAC109.00 Million ZAC117.00 Million ZAC135.00 Million ZAC62.00 Million ZAC67.00 Million
Depreciation ZAC2.09 Billion ZAC1.97 Billion ZAC1.79 Billion ZAC1.71 Billion ZAC1.65 Billion
Change in Cash ZAC-811.00 Million ZAC-273.00 Million ZAC2.52 Billion ZAC-984.00 Million ZAC338.00 Million

Aspen Pharmacare Holdings Ltd Earnings History — EPS Actual vs. Analyst Estimates

Track Aspen Pharmacare Holdings Ltd's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Mar 03, 2026 — — —
Dec 05, 2025 — — —
Sep 03, 2025 — — —
Mar 03, 2025 — — —
Dec 05, 2024 — — —